DOCSLIB.ORG

Curriculum Vitae

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Curriculum Vitae Kashkouli MB, CV CURRICULUM VITAE Mohsen Bahmani Kashkouli, MD Section Subject I Personal Information II 1. Executive Position 2. Journal Editor 3. Organizing a meeting 4. Journals’ reviewer, 5. Establishing an organization III Education IV Work Experience V Trained Fellows VI Edited Books/ Chapters VII Peer Reviewed Paper Publications VIII Courses Attended IX Directing Workshops/Courses/ Symposia X Conference Abstracts XI Invited (Guest) Speaker XII Awards XIII Innovations XIV Ongoing Research Projects XV Referees XVI Interests XVII Affiliations 1 Kashkouli MB, CV I. PERSONAL INFORMATION NAME: Mohsen Bahmani Kashkouli WORK ADDRESS University Hospital Private Office Rassoul Akram Hospital No.:49, West Brazil- South Sattarkhan-Niayesh Avenue Sheikhbahaee intersection, POBox: 14455-364 Tehran, Iran Tehran, Iran Phone: +98 21 66559595 Phone: +98 21 88065620 Fax: +98 21 66509162 Fax: +98 21 66558811 Email [email protected] DATE OF BIRTH: 09/January/1967 PLACE OF BIRTH: Gachsaran , Iran Language: Farsi, English, Turkish II. SCIENTIFIC & EXECUTIVE POSITIONS 1. Executive Positions 2. Professor, Head of Oculo-Facial Plastic Surgery, Rassoul Akram Hospital, Iran University of Medical Sciences (www.iums.ac.ir), Tehran, Iran. 3. Regional (Iran and Turkey) Vice President of Middle East African Council of Ophthalmology (MEACO).(www.meaco.org), Since Nov. 2019. 4. Vice President of Middle East African Council of Ophthalmology (MEACO) in Middle East (www.meaco.org), Since 2012. 5. Vice President, Middle East African Society of Ophthalmic Plastic and Reconstructive Surgery (MEASOPRS, www.meaco.org ), Since June 2016. 6. Scientific Coordinator, Middle East African Society of Ophthalmic Plastic and Reconstructive Surgery (MEASOPRS, www.meaco.org ), 2012-2016. 7. Scientific Director and chair of International relation section, Iranian Society of Ophthalmic Plastic and Reconstructive Suregry (IrSOPRS, www.irso.org/irsoprs), Tehran, Iran, Since 2007. 8. Head of International relations committee of the Iranian Society of Ophthalmology (www.irso.org) , 2009-2012. 2 Kashkouli MB, CV 9. Elected member of the Board of Directors of Iranian Society of Ophthalmology (www.irso.org) , 2009-2012. 10. Vice chairman in researches, Eye Departement and Eye Research Center, Iran University of Medical Sciences, Tehran, Iran, since 2003 (www.iraneyeresearch.com) 11. Member of Continuous Professional Development (CPD) committee of the Iranian Society of Ophthalmology, 2004-2006. 2. Journal Editor 1. Associate Editor, Middle East African Journal of Ophthalmology (MEAJO, www.meajo.org), since 2011. 2. Section Editor (Ophthalmic Plastic & Reconstructive), Journal of Ophthalmic & Vision Research (http://www.jovr.ir/index.php/jovr/about/editorialTeam) , since 2012. 3. Editorial borad member of Journal of Ocular Diseases and Therapeutics (J. Ocul. Dis. Ther.), since 2013. (http://savvysciencepublisher.com/editorial- board-member-jodt/) 4. Editorial Board member of the Journal of Surgery. ( http://www.hindawi.com/journals/jsur/editors/) 5. Editorial Board member of Edorium Journal of Ophthalmology, since 2015. (http://www.edoriumjournalofophthalmology.com/editorial-board.php) 6. Member of the Expert Board of the International Journal of Ophthalmology, 2013- 2014. 7. Editorial borad member of Journal of Ophthalmic and Optometric Sciences (JOOS), since 2016. (http://journals.sbmu.ac.ir/basir/about/editorialTeam ) 3. Organizing a meeting and research festivals 1. Member of organizing committee (oculo-facial plastic surgery section ) for 2020 WOC meeting. Cape Town, South Africa, 26-29 June 2020. 2. Scientific director of the 1st IranianOphthalmology Spring meeting. Tehran, Iran, April 2017. 3. Plastic convenor of the 2016 International MEACO meeting in Bahrain. http://www.meaco2016.com/conveners.php 4. Scientific director of the 9th Annual meeting of “Controversies in Ophthalmology.(www.iraneyeresearch.com), Tehran, Iran, July 2015. 3 Kashkouli MB, CV 5. Scientific director of XXII Congress of Iranian Society of Ophthalmology (IrSO) (www.irso.org ), Tehran, 18Oct-1Nov, 2012. 6. Member of scientific organization for the 35th annual meeting of the European Society of Ophthalmic Plastic and Reconstructive Surgery (ESOPRS), (http://esoprs2016.gr/?page_id=3406 ), Athens, Greece, September 2016. 7. Member of organizing committee in the 2016 MEACO meeting, May 2016 Bahrain. (www.MEACO.org). 8. Member of organizing committee in the International Council of Ophthalmology (ICO) for the World Ophthalmology Congress (WOC) 2012 Abu Dhabi, UAE - 2014 Tokyo, Japan - 2016 Mexicocity, Mexico. 9. Scientific Board of annual Congresses of Iranian Society of Ophthalmology (IrSO), 2002-present. (www.irso.org) 10. Scientific Board of annual meeting of Iranian Research Association for Vision and Ophthalmology (IRAVO), 2010-present. (www.iravo.org) 11. Member of Razi Research Festival Referees committee, Tehran, 2009- 2014.(www.razi.hbi.ir) 12. Head of Surgical Sciences Committee for the Razi Research Festival, Tehran, 2013. (www.razi.hbi.ir) 13. Member of Shams Visual Sciences Research festival Referees committee, Tehran, Since 2010. 4. Participation in Establishing a Training course/ Organization 1. PhD by research in Oculo-Facial Plastic Surgery at Rassoul Akram Hospital affiliated with Iran University of Medical Sciences, 2016. 2. One of the founding memebrs of Skull Base Research Center, Iran University of Medical Sciences, 2015. 3. One of the founding memebrs of Eye Research Center, Iran University of Medical Sciences, 2003. (www.iraneyeresaerch.com ) 4. The First approved independent Oculo-Facial Plastic Surgery Fellowship Training Center in Iran, Rassoul Akram Hospital, Iran University of Medical Sciences, 2008. 5. One of the founding memebrs of Iranian Society of Ophthalmic Plastic and Reconstructive Suregry (IrSOPRS, www.irso.org/irsoprs), Tehran, Iran, 2007. 4 Kashkouli MB, CV 6. One of the founding memebrs of Middle East African Society of Ophthalmic Plastic and Reconstructive Surgery (MEASOPRS, www.meaco.org/measoprs ), 2012. 5. International Journal Reviewer https://publons.com/researcher/294672/prof-mohsen-b-kashkouli/ 1. “Ocular Surface Disease”, USA, since 2017. 2. Journal of “ORBIT”, UK, since 2012. 3. “Acta Ophthalmologica”, USA, since 2012. 4. “Journal of American Academy of Pediatrics”, USA, since 2012. 5. “American Journal of Ophthalmology”, USA, sinec 2009. 6. “Ophthalmic Plastic and Reconstructive Surgery, OPRS”, journal of the American Society of OPRS, USA, since 2005. 7. “International Journal of Ophthalmology”, China, since 2012. 8. “Current Eye Research”, USA, since 2011. 9. " Indian Journal of Ophthalmology”, India, since 2009. 10. “Ophthalmology”, American Academy of Ophthalmologists, USA, since 2004. 11. " Aesthetic Plastic Surgery”, USA, since 2010. 12. " Anatomy Research International”, Hindawi publication corporation, USA, since 2011. 13. " BMC Ophthalmology”, USA, since 2009. 14. " Middle East African Journal of Ophthalmology”, since 2009. 15. " Ophthalmic physiology& optics”, USA, since 2008. 16. " Archives of Ophthalmology”, USA, since 2007. 17. " British Journal of Ophthalmology”, UK, since 2005. 18. Scientific Reviewer for the journal of “ Comprehensive Ophthalmology Update”, USA, since 2005. 19. “ Acta Medica Iranica”, Iran, since 2005. 5 Kashkouli MB, CV 20. “JCPSP, Journal of the College of Physicians and Surgeons Pakistan”, Pakistan, since 2004. 21. “ Saudi Medical Journal”, KSA, since 2013. 22. “ JOCO”, journal of the Iranian Society Of Ophthalmology, Iran, since 2000. III. EDUCATION BASIC MEDICAL EDUCATION AND QUALIFICATION MD Grade “A” graduation from Shiraz (Pahlavi) University 1992 Of Medical Sciences. Basic Sciences Shiraz Medical School 1985-1989 Student- and Externship Rotational courses in 1989-1991 different wards at Nemazi, Saadi, Hafez, and Shiraz general hospitals and Khalili Eye and Ear hospital. Internship Rotational courses at 1991-1992 aforementioned hospitals POSTGRADUATE EDUCATION AND QUALIFICATIONS Iranian Board Certification Iran University of Medical Sciences 1997 in Ophthalmology and Tehran, Iran Ophthalmic Surgery with “A” score. Ophthalmology Residency Rassoul Akram General hospital 1993-1997 Iran University of Medical Sciences Tehran, Iran FELLOWSHIPS AND POSTGRADUATE CERTIFICATIONS Ophthalmic Plastic Surgeries Norwich University Hospital March 1 2002- Clinical Senior Fellow Sponsored by the Royal College of March 31, 2003 Ophthalmologists (London, UK) and 6 Kashkouli MB, CV Approved by Cambridge Postgraduate Dean. United Kingdom Ophthalmic Plastic Surgeries Labbafinejad General June 21, 2000 Clinical training Hospital, Beheshti September 20, 2000 Beheshti University of Medical Sciences Tehran, Iran Ophthalmic Plastic Surgeries Farabi Eye Hospital, December 7,1999- Clinical training Tehran University of June 20, 2000 Medical Sciences, Tehran, Iran IV. WORKING EXPERIENCES Firoozbahram health centre General practitioner March 93-Sep.93 National Oil Company Hospital Ophthalmologist and 1997 - 98 ( everyday morning) Ophth.Surgeon Private Office Ophthalmologist and 1997 - 98 ( everyday afternoon) Ophth.Surgeon Iran University of Assistant professor, Medical Sciences Director, Eye Plastic Nov. 1998 – 2004 Unit and Educational Supervisor. Iran University of Associate Professor, 2004 - 2009 Medical Sciences Head of Oculo-Facial Plastic Surgery Unit and Vice chairman in research Iran University of Professor Medical Sciences (One of the youngest to achieve this position) 2009- 2010 Tehran University of Professor 2010- 2012 7 Kashkouli
Load more

Recommended publications
  • Icare Eye Hospital Rate List 2015
    ICARE EYE HOSPITAL & POST GRADUATE INSTITUTE E-3A, Sector – 26, Noida – 201301 Tel:- 0120-2477600 / 02, Counselor: 0120-2477621 Fax: 0120-2556389 / Appointments: 9811880015 Email: [email protected] / Web: www.icarehospital.org ICARE EYE HOSPITAL RATE LIST 2015 S No. PARTICULAR TARIFF (₹) I CONSULTATION NEW PATIENT VALID FOR 7 DAYS (FIRST TIME CONSULTATION : REGISTRATION + 1 ₹ 600/- CONSULTATION) 2 REVIEW CONSULTATION VALID FOR 7 DAYS ₹ 500/- 3 EMERGENCY CONSULTATION FOR 7 DAYS ₹ 800/- 4 LOW VISUAL AIDS ASSESSMENT CHARGES ₹ 600/- 5 VISION THERAPY CHARGES FOR PER SITTING ₹ 200/- 6 COST OF VISION THERAPY SOFTWARE (CD) ₹ 6,000/- 7 AMBLYOPIA (CD) ₹ 4,000/- II INVESTIGATIONS 1 Digital F.F.A (Fundus Fluoroscein Angiography)(Inclusive of Fundus photo) ₹ 2,500/- 2 Colour Fundus Photo - Digital ₹ 600/- 3 Colour Slit-lamp photo ₹ 600/- 4 Duplicate color prints (FFA/OCT/CLINICAL PHOTO) ₹ 300/- 5 Orthoptic ₹ 250/- 6 OCT (Optical Coherence Tomography) ₹ 2,500/- A Repeat OCT (within 2 months) with printout ₹ 800/- B Anterior Segment OCT ₹ 2,500/- 7 Ultrasonography (U/S) A A Scan – Single Eye ₹ 600/- B B Scan – Single Eye ₹ 1,000/- C UBM - Single Eye ₹ 1,500/- 8 Computerized field analysis A Humphrey Visual Fields (HVF) both eyes ₹ 1,500/- B Humphrey Visual Fields (HVF) One eye ₹ 750/- 9 Diurnal Variation of Tension (Day DVT ) A 5 times tension (Done in both eyes)] ₹ 500/- Page 1 10 Pachymetry (Both eyes) A Ultrasound (Central Corneal Thickness- CST) ₹ 600/- B Optical ₹ 600/- 11 Corneal Topography A Single Eye ₹ 1,000/- B Both Eyes ₹ 2,000/- 12
    [Show full text]
  • Local Coverage Determination (LCD): Diagnostic Evaluation and Medical Management of Moderate-Severe Dry Eye Disease (DED) (L36232)
    Local Coverage Determination (LCD): Diagnostic Evaluation and Medical Management of Moderate-Severe Dry Eye Disease (DED) (L36232) Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website. Contractor Information CONTRACTOR NAME CONTRACT TYPE CONTRACT NUMBER JURISDICTION STATE(S) First Coast Service Options, Inc. A and B MAC 09101 - MAC A J - N Florida First Coast Service Options, Inc. A and B MAC 09102 - MAC B J - N Florida First Coast Service Options, Inc. A and B MAC 09201 - MAC A J - N Puerto Rico Virgin Islands First Coast Service Options, Inc. A and B MAC 09202 - MAC B J - N Puerto Rico First Coast Service Options, Inc. A and B MAC 09302 - MAC B J - N Virgin Islands LCD Information Document Information LCD ID Original Effective Date L36232 For services performed on or after 11/22/2015 LCD Title Revision Effective Date Diagnostic Evaluation and Medical Management of For services performed on or after 01/08/2019 Moderate-Severe Dry Eye Disease (DED) Revision Ending Date Proposed LCD in Comment Period N/A N/A Retirement Date Source Proposed LCD N/A DL36232 Notice Period Start Date AMA CPT / ADA CDT / AHA NUBC Copyright 10/08/2015 Statement CPT codes, descriptions and other data only are Notice Period End Date copyright 2019 American Medical Association. All Rights 11/22/2015 Reserved. Applicable FARS/HHSARS apply. Current Dental Terminology © 2019 American Dental Association. All rights reserved. Copyright © 2019, the American Hospital Association, Created on 01/02/2020. Page 1 of 12 Chicago, Illinois.
    [Show full text]
  • To:$M.R$Ahmad$Shahid$ Special$Rapporteur$On$The
    To:$M.r$Ahmad$Shahid$ Special$Rapporteur$on$the$human$rights$situation$in$Iran$ $ Dear%Sir,% % such%as%equal%rights%to%education%for%everyone,%preventing%the%dismissal%and%forced%retirements%of% dissident%university%professors,%right%of%research%without%limitations%in%universities%and%to%sum%up% expansion%of%academic%liberties.%Student%activists%have%also%been%pursuing%basic%rights%of%the%people% such%as%freedom%of%speech,%press,%and%rallies,%free%formation%and%function%of%parties,%syndicates,%civil% associations%and%also%regard%of%democratic%principles%in%the%political%structure%for%many%years.% % But%unfortunately%the%regime%has%rarely%been%friendly%towards%students.%They%have%always%tried%to%force% from%education,%banishments%to%universities%in%remote%cities,%arrests,%prosecutions%and%heavy%sentences% of%lashing,%prison%and%even%incarceration%in%banishment,%all%for%peaceful%and%lawful%pursuit%of%the% previously%mentioned%demands.%Demands%which%according%to%the%human%rights%charter%are%considered% the%most%basic%rights%of%every%human%being%and%Islamic%Republic%of%Iran%as%a%subscriber%is%bound%to% uphold.% % The%government%also%attempts%to%shut%down%any%student%associations%which%are%active%in%peaceful%and% lawful%criticism,%and%their%members%are%subjected%to%all%sorts%of%pressures%and%restrictions%to%stop%them.% Islamic%Associations%for%example%which%have%over%60%years%of%history%almost%twice%as%of%the%Islamic% republic%regimeE%and%in%recent%years%have%been%the%only%official%criticizing%student%associations%in% universities,%despite%their%massive%number%of%student%members,%have%been%shut%down%by%the%
    [Show full text]
  • Newsletter Spring 2007 Final.Indd
    CENTER FOR IRANIAN STUDIES NEWSLETTER Vol. 19, No. 1 SIPA-Columbia University-New York Spring 2007 ENCYCLOPÆDIA IRANICA GALA BENEFIT FASCICLE 1 OF VOLUME XIV PUBLISHED DINNER EW ORK ITY Fascicle 1 of Volume XIV features ISLAMIC History; v. LOCAL HISTORIOG- N Y C the remaining sections of the entry RAPHY; vi. MEDIEVAL PERIOD; vii. THE MAY 5, 2007 ISFAHAN, a series of 22 articles that SAFAVID PERIOD; VIII. THE QAJAR began in Fascicle 6 of Volume XIII. PERIOD; ix. THE PAHLAVI PERIOD The city of Isfahan has served as one AND POST-REVOLUTION ERA; x. of the most important urban centers MONUMENTS; xi. ISFAHAN SCHOOL on the Iranian plateau since ancient OF PAINTING AND CALLIGRAPHY; xii. times and has gained, over centuries BAZAAR, PLAN AND FUNCTION; xiii. of urbanization, many significant monu- CRAFTS; xiv. MODERN ECONOMY AND IN- ments. Isfahan is home to a number of DUSTRIES; xv. EDUCATION AND CULTURAL monuments that have been designated AFFAIRS; xvi. ISFAHAN IN THE MIRROR OF by UNESCO as World Heritage Sites. It FOLKLORE AND LEGEND; xvii. ARMENIAN is Persiaʼs third largest city, after Tehran COMMUNITY (referred to JULFA); xviii. and Mashad, with a population of over JEWISH COMMUNITY; xix. JEWISH DIA- 1.4 million in 2004. LECTS; xx. GEOGRAPHY OF THE MEDIAN The series explores the following DIALECTS; xxi. PROVINCIAL DIALECTS; Dr. Maryam Safai topics: i. GEOGRAPHY; ii. HISTORICAL XXII. GAZI DIALECT. GEOGRAPHY; iii. POPULATION; iv. PRE- Continued on page 2 The Gala Benefit Dinner for the Encyclopædia Iranica will be held in the Rotunda of Columbia University MAJOR DONORS TO THE on May 5, 2007 from 6:30 PM to 1:30 AM.
    [Show full text]
  • Cosmetic Lateral Canthoplasty: Lateral Topic Canthoplasty to Lengthen the Lateral Canthal Angle and Correct the Outer Tail of the Eye
    Cosmetic Lateral Canthoplasty: Lateral Topic Canthoplasty to Lengthen the Lateral Canthal Angle and Correct the Outer Tail of the Eye Soo Wook Chae1, Byung Min Yun2 1BY Plastic Surgery Clinic, Seoul; 2Department of Plastic and Reconstructive Surgery, Jeju National University, Jeju, Korea There are many women who want larger and brighter eyes that will give a favorable impression. Correspondence: Soo Wook Chae Surgical methods that make the eye larger and brighter include double eyelidplasty, epican- BY Plastic Surgery Clinic, Wookyung Bldg. 5th Fl., 466 Apgujeong-ro, thoplasty, as well as lateral canthoplasty. Double eyelidplasty produces changes in the vertical Gangnam-gu, Seoul 06015, Korea dimension of the eyes, whereas epicanthoplasty and lateral canthoplasty create changes in Tel: +82-2-541-5522 the horizontal dimension of the eyes. Epicanthoplasty, a surgical procedure which enlarges Fax: +82-2-545-8743 the eye horizontally, is performed at the inner corner of the eye, whereas lateral canthoplasty E-mail: [email protected] enlarges the outer edge of the eye. In particular, if the slant of the palpebral fissure is raised and the horizontal dimension of the palpebral fissure is short, adjusting the slant of the pal- pebral fissure through lateral canthoplasty can achieve an enlargement of eye width and smoother features. Depending on the patient’s condition, even better results can be achieved if this procedure is performed in conjunction with other procedures, such as double eyelid- plasty, epicanthoplasty, eye roll formation surgery, fat graft, and facial bone contouring sur- gery. In this paper, the authors will introduce in detail their surgical method for a cosmetic lateral canthoplasty that lengthens the lateral canthal angle and corrects the outer tail of the eyes, in order to ease the unfavorable impression.
    [Show full text]
  • Cataract Surgery
    Cataract surgery From Wikipedia, the free encyclopedia Jump to: navigation, search This article includes a list of references, related reading or external links, but its sources remain unclear because it lacks inline citations. Please improve this article by introducing more precise citations. (May 2011) Cataract surgery Intervention Cataract in Human Eye- Magnified view seen on examination with a slit lamp ICD-9-CM 13.19 MeSH D002387 Cataract surgery is the removal of the natural lens of the eye (also called "crystalline lens") that has developed an opacification, which is referred to as a cataract. Metabolic changes of the crystalline lens fibers over time lead to the development of the cataract and loss of transparency, causing impairment or loss of vision. Many patients' first symptoms are strong glare from lights and small light sources at night, along with reduced acuity at low light levels. During cataract surgery, a patient's cloudy natural lens is removed and replaced with a synthetic lens to restore the lens's transparency.[1] Following surgical removal of the natural lens, an artificial intraocular lens implant is inserted (eye surgeons say that the lens is "implanted"). Cataract surgery is generally performed by an ophthalmologist (eye surgeon) in an ambulatory (rather than inpatient) setting, in a surgical center or hospital, using local anesthesia (either topical, peribulbar, or retrobulbar), usually causing little or no discomfort to the patient. Well over 90% of operations are successful in restoring useful vision, with a low complication rate.[2] Day care, high volume, minimally invasive, small incision phacoemulsification with quick post-op recovery has become the standard of care in cataract surgery all over the world.
    [Show full text]
  • Fixing Patients' Problems
    CAN TABLETS WORK FOR EMR? P. 12 • CODING TIPS FOR CROSS-LINKING P. 16 A FRESH ANGLE ON RESIDENT TRAINING P. 68 • SIXTH CRANIAL NERVE DYSFUNCTION IN KIDS P. 72 Review of Ophthalmology Vol. XXIV, No. 4 • April 2017 • Fighting for Patient Care • Avoiding Problems Using OCT • Managing Refractive Surprises Problems • Optical Biometry Roundup Care • Avoiding No. 4 • April 2017 • Fighting for Patient Review of Ophthalmology Vol. XXIV, STEM THE TIDE OF EXCESSIVE TEARING P. 76 • POST-INJECTION IOP SPIKES P. 96 April 2017 reviewofophthalmology.com Fixing Patients’ Problems Expert surgeons give you the tools you need to succeed. ALSO INSIDE: Sizing Up Optical Biometers P. 58 001_rp0417_fc-WB.indd 1 3/24/17 12:52 PM VISIT US AT ASCRS BOOTH #1022 It’s all in CHOOSE A SYSTEM THAT EMPOWERS YOUR EVERY MOVE. Technique is more than just the motions. Purposefully engineered for exceptional versatility and high-quality performance, the WHITESTAR SIGNATURE® PRO Phacoemulsification System gives you the clinical flexibility, confidence and control to free your focus for what matters most in each procedure. How do you phaco? Join the conversation at WWW.ABBOTTPHACO.COM Rx Only INDICATIONS: The WHITESTAR SIGNATURE® PRO System is a modular ophthalmic microsurgical system that facilitates anterior segment (cataract) surgery. The modular design allows the users to configure the system to meet their surgical requirements. IMPORTANT SAFETY INFORMATION: Risks and complications of cataract surgery may include broken ocular capsule or corneal burn. This device is only to be used by a trained, licensed physician. ATTENTION: Reference the labeling for a complete listing of Indications and Important Safety Information.
    [Show full text]
  • Primary External Dacryocystorhinostomy
    11 Primary External Dacryocystorhinostomy Richard H. Hart, Suzanne Powrie, and Geoffrey E. Rose The watering eye may be the result of excessive tear production, abnor- malities of lid position or movement, lacrimal canalicular pump failure, or obstruction of the outfl ow tract. With external dacryocystorhinos- tomy (DCR), the lacrimal sac is directly incorporated into the lateral wall of the nose, so that the canaliculi drain directly into the nasal cavity. The aims of surgery are twofold: to eliminate fl uid and mucus reten- tion within the lacrimal sac and prevent sac enlargement (as a muco- cele) – the latter leading to intermittent viscous ocular discharge – and to bypass the higher hydraulic resistance of the nasolacrimal duct, thereby increasing tear conductance and aiding the relief of epiphora. Indications for Surgery 1. Primary acquired nasolacrimal duct obstruction 2. Secondary acquired nasolacrimal duct obstruction attributed, for example, to dacryolithiasis, endonasal surgery, infl ammatory nasal or sinus disease, or prior midfacial injury 3. Persistent congenital nasolacrimal duct obstruction, often after unsuccessful probing or intubation of the nasolacrimal duct 4. Functional obstruction of lacrimal outfl ow with decreased tear conductance as a result of: (a) Stenosis, but not occlusion, of the nasolacrimal duct (b) Lacrimal canalicular pump failure from age-related laxity of the lower eyelid, or after facial nerve palsy 5. Acute or chronic dacryocystitis; the former group requiring initial treatment with systemic antibiotics Surgical Principles External DCR should establish a low-resistance drainage pathway between the conjunctival tear sac and the nasal cavity, by conversion of the lacrimal sac into part of the lateral nasal wall.
    [Show full text]
  • Summary of Safety and Effectivness (SSED)
    SUMMARY OF SAFETY AND EFFECTIVENESS DATA (SSED) I. GENERAL INFORMATION Device Generic Name: Intraocular Pressure Lowering Implant Device Trade Name: Hydrus® Microstent Device Procode: OGO Applicant’s Name and Address: Ivantis, Inc. 38 Discovery, Suite 150 Irvine, CA 92618 Date(s) of Panel Recommendation: None Premarket Approval Application (PMA) Number: P170034 Date of FDA Notice of Approval: August 10, 2018 II. INDICATIONS FOR USE The Hydrus® Microstent is indicated for use in conjunction with cataract surgery for the reduction of intraocular pressure (IOP) in adult patients with mild to moderate primary open-angle glaucoma (POAG). III. CONTRAINDICATIONS The Hydrus® Microstent is contraindicated under the following circumstances or conditions: • In eyes with angle closure glaucoma • In eyes with traumatic, malignant, uveitic, or neovascular glaucoma or discernible congenital anomalies of the anterior chamber (AC) angle. IV. WARNINGS AND PRECAUTIONS The warnings and precautions can be found in the Hydrus® Microstent labeling. V. DEVICE DESCRIPTION The Hydrus® Microstent is a crescent-shaped, implantable microstent pre-loaded onto a hand-held delivery system. The microstent (Figure 1) is composed of nitinol, a metal alloy of nickel (Ni) and titanium (Ti) with super-elastic properties. The implant is laser cut from nitinol tubing to a design with alternating “spines” for structural support and “windows” to provide PMA P170034: FDA Summary of Safety and Effectiveness Data Page 1 outflow pathways for aqueous humor. After laser cutting, the shape of the implant is heat-set to a curvature intended to match the curvature of Schlemm’s canal and is electro- polished to create a smooth surface. The microstent is approximately 8 mm in overall length with major and minor axes of 292 µm and 185 µm, respectively.
    [Show full text]
  • Operative Dictations in Ophthalmology Eric D
    Operative Dictations in Ophthalmology Eric D. Rosenberg • Alanna S. Nattis Richard J. Nattis Editors Operative Dictations in Ophthalmology Editors Eric D. Rosenberg Alanna S. Nattis Ophthalmology Resident Cornea and Refractive Surgery Fellow Department of Ophthalmology Ophthalmic Consultants of Long Island New York Medical College Rockville Centre, NY, USA Valhalla, NY, USA Richard J. Nattis Chief of Ophthalmology and Clinical Professor Department of Ophthalmology Good Samaritan Hospital West Islip, NY, USA ISBN 978-3-319-45494-8 ISBN 978-3-319-45495-5 (eBook) DOI 10.1007/978-3-319-45495-5 Library of Congress Control Number: 2017932292 © Springer International Publishing Switzerland 2017 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, express or implied, with respect to the material contained herein or for any errors or omissions that may have been made.
    [Show full text]
  • Department of the Treasury
    Vol. 81 Monday, No. 49 March 14, 2016 Part IV Department of the Treasury Office of Foreign Assets Control Changes to Sanctions Lists Administered by the Office of Foreign Assets Control on Implementation Day Under the Joint Comprehensive Plan of Action; Notice VerDate Sep<11>2014 14:39 Mar 11, 2016 Jkt 238001 PO 00000 Frm 00001 Fmt 4717 Sfmt 4717 E:\FR\FM\14MRN2.SGM 14MRN2 jstallworth on DSK7TPTVN1PROD with NOTICES 13562 Federal Register / Vol. 81, No. 49 / Monday, March 14, 2016 / Notices DEPARTMENT OF THE TREASURY Department of the Treasury (not toll free Individuals numbers). 1. AFZALI, Ali, c/o Bank Mellat, Tehran, Office of Foreign Assets Control SUPPLEMENTARY INFORMATION: Iran; DOB 01 Jul 1967; nationality Iran; Electronic and Facsimile Availability Additional Sanctions Information—Subject Changes to Sanctions Lists to Secondary Sanctions (individual) Administered by the Office of Foreign The SDN List, the FSE List, the NS– [NPWMD] [IFSR]. Assets Control on Implementation Day ISA List, the E.O. 13599 List, and 2. AGHA–JANI, Dawood (a.k.a. Under the Joint Comprehensive Plan additional information concerning the AGHAJANI, Davood; a.k.a. AGHAJANI, of Action JCPOA and OFAC sanctions programs Davoud; a.k.a. AGHAJANI, Davud; a.k.a. are available from OFAC’s Web site AGHAJANI, Kalkhoran Davood; a.k.a. AGENCY: Office of Foreign Assets AQAJANI KHAMENA, Da’ud); DOB 23 Apr (www.treas.gov/ofac). Certain general Control, Treasury Department. 1957; POB Ardebil, Iran; nationality Iran; information pertaining to OFAC’s Additional Sanctions Information—Subject ACTION: Notice. sanctions programs is also available via to Secondary Sanctions; Passport I5824769 facsimile through a 24-hour fax-on- (Iran) (individual) [NPWMD] [IFSR].
    [Show full text]
  • Optical Coherence Tomography in Age-Related Macular Degeneration 1St Edition Principles 1
    OPTICAL COHERENCE TOMOGRAPHY IN AGE- RELATED MACULAR DEGENERATION 1ST EDITION DOWNLOAD FREE Gabriel Coscas | 9783662505618 | | | | | Atlas of Retinal OCT: Optical Coherence Tomography Fluoroscopy Dental panoramic radiography X-ray motion analysis. Lay summary — Los Angeles Times September 4, White light is an example of a broadband source with lower power. OCT is based on low-coherence interferometry. October Any light that is outside the short coherence length will not interfere. An imaging approach to temporal OCT was developed by Claude Boccara's team in[24] with an acquisition of the images without beam scanning. Light with broad bandwidths can be generated by using superluminescent diodes or lasers with extremely short pulses femtosecond lasers. Bibcode : OExpr. April Learn how and when to remove this template message. Substances Angiogenesis Inhibitors. Synthetic array heterodyne detection offers another approach to this problem without the need for high dispersion. Free Shipping Free global shipping No minimum order. Therefore, translating one arm of the interferometer has two functions; depth scanning and a Doppler-shifted optical carrier are accomplished by pathlength variation. Optic Neuropathies and Papilledema 6. American Journal of Ophthalmology. We are always looking for ways to improve customer experience on Elsevier. Optical Coherence Tomography in Age-Related Macular Degeneration 1st edition Principles 1. Optical Coherence Tomography in Age-Related Macular Degeneration 1st edition Clinics. A wide range of fundus imaging modalities are now available, and this book explains the respective value of each technique. Intravascular OCT has been investigated for use in neurovascular applications, too, including imaging for guiding endovascular treatment of ischemic stroke and brain aneurysms.
    [Show full text]